Hepatology · Budd-Chiari syndrome

Budd-Chiari Syndrome (Hepatic Vein Thrombosis): A Patient Guide

At a Glance

Budd-Chiari syndrome occurs when veins draining the liver are narrowed or blocked, causing blood to back up. Care usually combines blood-thinning medication, investigation of clotting causes, treatment of the blockage when needed, and regular imaging; advanced cases may require a liver transplant.

Budd-Chiari Syndrome (BCS), often referred to broadly as hepatic venous outflow obstruction, is a rare condition that occurs when the flow of blood out of your liver becomes narrowed or blocked. Because the liver is a highly vascular organ, these “exit routes” are essential for its function; when they are obstructed, blood backs up into the liver tissue, causing it to become congested and swollen ^[1]. This internal pressure can lead to various symptoms, such as abdominal pain and fluid buildup, as the liver struggles to process the volume of blood it receives from the rest of the body ^[2]^[3]. While often caused by a blood clot (thrombosis) in a hepatic vein, BCS can also involve webs, vessel narrowing (stenosis), or blockages in the inferior vena cava.

The root cause of this blockage is rarely a random event. In many cases, the blood has become prone to clotting because of an underlying condition—such as a clonal blood disorder known as a myeloproliferative neoplasm (MPN) or another genetic or acquired predisposition to clotting ^[4]^[5]. Identifying this “why” is a crucial part of the diagnostic process, as it helps your doctors treat not just the current blockage, but the systemic environment that allowed the clot to form ^[6]. In some cases, a clear cause cannot be identified, or several risk factors may coexist.

Managing this condition requires a highly coordinated effort from a multidisciplinary team. Because BCS involves both the liver and the blood, you will likely work with a hepatologist (liver specialist), a hematologist (blood specialist), and an interventional radiologist (a specialist who performs minimally invasive procedures on blood vessels) ^[7]^[8]. Because BCS is so rare, affecting roughly 0.1 to 10 in a million people depending on the region, this team-based approach at a specialized center is considered the standard of care to ensure your treatment aligns with the most current medical evidence ^[3]^[9].

Treatment generally follows a flexible, anatomy-guided framework ^[10]. It almost always involves medications to thin the blood and manage symptoms. Depending on the location of your blockage and how your liver is functioning, your team may promptly escalate to minimally invasive procedures like angioplasty, stenting, or a specialized bypass called a TIPS ^[11]^[12]. While a liver transplant is available as a final safety net for advanced or rapidly progressing cases, many patients successfully manage the condition for years through this individualized path of care ^[13]^[14].

Living with Budd-Chiari Syndrome is a long-term journey that centers on protection and prevention. It often requires a commitment to indefinite blood-thinning medication (tailored to your specific bleeding risks) and regular imaging to monitor the health of your liver and the flow of your veins ^[15]^[16]. While the diagnosis is complex, the goal of your care team is to stabilize your liver function and provide a clear, manageable path forward that allows you to maintain your quality of life ^[14]^[17].

In this guide

6 chapters

Orientation and Validation: Understanding Budd-Chiari Syndrome

Learn what Budd-Chiari syndrome means, where hepatic vein blockage occurs, how it is evaluated, and why coordinated care from a specialist liver team matters.

Recognizing Symptoms and Emergency Warning Signs

Learn about hepatic vein thrombosis and Budd-Chiari syndrome, including abdominal swelling and jaundice plus bleeding, confusion, and other emergency warning signs

Causes and Clues: Why Do Blockages Form?

Learn what causes Budd-Chiari syndrome and hepatic vein thrombosis, including MPNs, JAK2 mutations, inherited clotting disorders, hormones, tumors, and SOS.

Navigating Your Diagnosis: Scans, Reports, and Biopsies

Learn how Budd-Chiari syndrome is diagnosed with Doppler ultrasound, CT, MRI, blood tests, venography, and biopsy, plus key report terms to review with your doctor

The Treatment Pathway: A Step-by-Step Approach

Learn how Budd-Chiari syndrome is treated, from blood thinners and diuretics to angioplasty, TIPS, and liver transplant, plus when doctors escalate care.

Living Well: Long-Term Monitoring and Daily Care

Learn how people with Budd-Chiari syndrome manage lifelong blood thinners, Doppler scans, liver cancer screening, ascites, and daily warning signs to report.

Common questions in this guide

What is Budd-Chiari syndrome, and what happens to the liver?

Budd-Chiari syndrome occurs when the veins that carry blood out of the liver are narrowed or blocked, sometimes by a blood clot. Blood then backs up in the liver, causing congestion and swelling that can lead to abdominal pain, fluid buildup, and reduced liver function.

Why did I develop hepatic vein thrombosis?

Many people with Budd-Chiari syndrome have an underlying tendency to form blood clots, such as a myeloproliferative neoplasm or a genetic or acquired clotting predisposition. Sometimes no single cause is found, and more than one risk factor may contribute.

Which doctors usually manage Budd-Chiari syndrome?

Care commonly involves a hepatologist, hematologist, and interventional radiologist working together. Because the condition is rare, treatment at a specialized center may help the team coordinate decisions using current medical evidence.

What treatments can unblock or bypass the affected veins?

Treatment usually includes blood-thinning medication to reduce the risk of additional clots and care to manage symptoms. Depending on the blockage and liver function, doctors may use angioplasty, a stent, or a TIPS bypass procedure; a liver transplant may be considered for advanced or rapidly worsening disease.

Will Budd-Chiari syndrome require lifelong treatment and monitoring?

Many people need long-term or indefinite blood-thinning medication, but the plan is adjusted to balance clot prevention with bleeding risk. Regular imaging is commonly used to check liver health and blood flow, while the exact schedule depends on your condition.

Curated prompts to bring to your next appointment.

1.Which specialists are currently on my multidisciplinary team, and do they have experience managing Budd-Chiari Syndrome?
2.Where exactly is the blockage in my liver’s vascular system, and how is it affecting my liver function?
3.What specific blood tests are being used to find the underlying cause of my clotting?
4.Based on the current state of my liver and the location of the blockage, where are we starting in the treatment process?
5.What is our long-term plan for monitoring my blood flow and screening for potential complications?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (17)

1
Diagnosis of Budd-Chiari syndrome.
Van Wettere M, Bruno O, Rautou PE, et al.
Abdominal radiology (New York) 2018; (43(8)):1896-1907 doi:10.1007/s00261-017-1447-2.
PMID: 29285598
2
[Primitive Budd-Chiari syndrome: a diagnostic and therapeutic challenge].
Benali F, Aqodad N
The Pan African medical journal 2020; (37()):142 doi:10.11604/pamj.2020.37.142.25109.
PMID: 33425175
3
Budd-Chiari syndrome: investigation, treatment and outcomes.
Goel RM, Johnston EL, Patel KV, Wong T
Postgraduate medical journal 2015; (91(1082)):692-7 doi:10.1136/postgradmedj-2015-133402.
PMID: 26494427
4
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.
De Stefano V, Qi X, Betti S, Rossi E
Thrombosis and haemostasis 2016; (115(2)):240-9 doi:10.1160/TH15-04-0326.
PMID: 26333846
5
The epidemiology of Budd-Chiari syndrome in France.
Ollivier-Hourmand I, Allaire M, Goutte N, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2018; (50(9)):931-937 doi:10.1016/j.dld.2018.04.004.
PMID: 29803757
6
Budd-Chiari syndrome: imaging review.
Bansal V, Gupta P, Sinha S, et al.
The British journal of radiology 2018; (91(1092)):20180441 doi:10.1259/bjr.20180441.
PMID: 30004805
7
EASL Clinical Practice Guidelines on vascular diseases of the liver.

Journal of hepatology 2025; doi:10.1016/j.jhep.2025.08.001.
PMID: 41224629
8
Pediatric Hepatic Venous Outflow Tract Obstruction: Experience from a Transplant Center.
Malik I, Bhatia V, Kumar K, et al.
Indian pediatrics 2019; (56(11)):965-967.
PMID: 31729328
9
Budd-Chiari Syndrome-A Single Center Experience From the United Kingdom.
Mann JP, Ikram F, Modin L, et al.
Journal of pediatric gastroenterology and nutrition 2023; (77(4)):455-459 doi:10.1097/MPG.0000000000003860.
PMID: 37314703
10
Budd-Chiari syndrome/hepatic venous outflow tract obstruction.
Valla DC
Hepatology international 2018; (12(Suppl 1)):168-180 doi:10.1007/s12072-017-9810-5.
PMID: 28685257
11
Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective.
Khan F, Mehrzad H, Tripathi D
Journal of translational internal medicine 2018; (6(3)):97-104 doi:10.2478/jtim-2018-0022.
PMID: 30425945
12
Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome.
Tripathi D, Sunderraj L, Vemala V, et al.
Liver international : official journal of the International Association for the Study of the Liver 2017; (37(1)):111-120 doi:10.1111/liv.13180.
PMID: 27254473
13
Budd-chiari syndrome causing acute liver failure: A multicenter case series.
Parekh J, Matei VM, Canas-Coto A, et al.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2017; (23(2)):135-142 doi:10.1002/lt.24643.
PMID: 27656864
14
Budd-Chiari syndrome: reassessment of a step-wise treatment strategy.
Martens P, Maleux GA, Devos T, et al.
Acta gastro-enterologica Belgica 2015; (78(3)):299-305.
PMID: 26448411
15
Budd-Chiari Syndrome: An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed.
Haque LYK, Lim JK
Clinics in liver disease 2020; (24(3)):453-481 doi:10.1016/j.cld.2020.04.012.
PMID: 32620283
16
MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up.
García-Criado Á, Rimola J, Seijo S, et al.
Liver cancer 2024; (13(2)):203-214 doi:10.1159/000533598.
PMID: 38751551
17
Complications of transjugular intrahepatic portosystemic shunt (TIPS) in the era of the stent graft - What the interventionists need to know?
Patel RK, Chandel K, Tripathy TP, Mukund A
European journal of radiology 2021; (144()):109986 doi:10.1016/j.ejrad.2021.109986.
PMID: 34619618

This page explains Budd-Chiari syndrome and hepatic vein thrombosis for educational purposes only; it does not replace medical advice. Your hepatologist, hematologist, and interventional radiologist can interpret your findings and tailor treatment.

Get notified when new evidence is published on hepatic vein thrombosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents